{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:18:52Z","timestamp":1778901532207,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/17512433.2023.2279736","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T15:05:50Z","timestamp":1699628750000},"page":"1163-1173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Overcoming blinding confounds in psychedelic randomized controlled trials using biomarker driven causal mediation analysis"],"prefix":"10.1080","volume":"16","author":[{"given":"Suresh D","family":"Muthukumaraswamy","sequence":"first","affiliation":[{"name":"School of Pharmacy, The University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_5_9_1","unstructured":"https:\/\/compasspathways.com\/compass-pathways-announces-phase-3-pivotal-program-design-for-comp360-in-treatment-resistant-depression-at-capital-markets-day\/. Retrieved Jun 6 2023."},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1037\/h0037350"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1986.10478354"},{"key":"e_1_3_5_13_1","volume-title":"Causal inference: what if","author":"MA H","year":"2020","unstructured":"MA H, JM R. Causal inference: what if. Boca Raton: Chapman & Hall\/CRC; 2020."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139025751"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210386779"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S52209"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00733"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221081763"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1037\/pst0000172"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00293"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291723001289"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1214\/14-STS501"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06123-7"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080407"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201400049"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0020761"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1214\/10-STS321"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.51.6.1173"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/10705511.2020.1777133"},{"key":"e_1_3_5_30_1","volume-title":"A review of causal mediation analysis for assessing direct and indirect treatment effects","author":"Huber M","year":"2019","unstructured":"Huber M. A review of causal mediation analysis for assessing direct and indirect treatment effects. Fribourg, Switzerland: FSES Working Papers 500, Faculty of Economics and Social Sciences, University of Freiburg; 2019."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0031034"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104689"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep46421"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.724606"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.118.017160"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0325-4"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09091379"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722001301"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774518760300"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14075"},{"key":"e_1_3_5_42_1","unstructured":"Grinspoon L. Psychedelic drugs reconsidered\/Lester Grinspoon & James B. Bakalar. In: Bakalar J editor. (NY): Basic Books; 1979. Accessed from https:\/\/nla.gov.au\/nla.cat-vn1097578)"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0957154X16648822"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1086\/383628"},{"key":"e_1_3_5_45_1","volume-title":"The beyond within: the LSD story","author":"Cohen S","year":"1964","unstructured":"Cohen S. The beyond within: the LSD story. (NY): Atheneum; 1964."},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1951473"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06221-6"},{"key":"e_1_3_5_48_1","unstructured":"https:\/\/www.tga.gov.au\/news\/media-releases\/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists. Retrieved 30th May 2023."},{"key":"e_1_3_5_49_1","unstructured":"Food and Drug Administration. Demonstrating substantial evidence of effectiveness for human drug and biological products. 2019."}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2023.2279736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:36:01Z","timestamp":1727202961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2023.2279736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/17512433.2023.2279736"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2023.2279736","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}